Can You Get COVID-19 Again? Replay our May 22 HDLive!

Follow Our Live Coverage of COVID-19 Developments

Zegerid OTC Approved for Frequent Heartburn

In original prescription formula

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

WEDNESDAY, Dec. 2, 2009 (HealthDay News) -- Merck & Co.'s Zegerid OTC (omeprazole/sodium bicarbonate) has been approved by the U.S. Food and Drug Administration to treat frequent heartburn, the company said Wednesday in a news release.

The over-the-counter product, to be available in the first half of next year, contains prescription Zegerid's original formula, Merck said. The 14-day course of treatment is taken once daily to treat frequent heartburn for up to 24 hours.

Zegerid OTC is a proton pump inhibitor (PPI), which works to suppress stomach acid.

Some 50 million adults in the United States have heartburn symptoms more than twice weekly (defined as frequent heartburn), and as many as 25 million have heartburn daily, the company said.

More information

The U.S. National Library of Medicine has more about heartburn.


Last Updated: